Latest Market News

Clarity Pharmaceuticals confirms continuation of its SECuRE Phase II trial for Cu-SAR-bisPSMA without protocol changes, reporting encouraging safety and efficacy data in metastatic prostate cancer patients.

Beacon Minerals reported a solid December quarter with 7,310 ounces of gold produced and a 23% rise in realised gold prices, driving revenue to $53.47 million. The company is transitioning mining operations while maintaining strong recovery rates and shareholder returns.

Victory Metals reports breakthrough metallurgical results at North Stanmore, slashing rare earth leach times and boosting critical mineral grades, while advancing strategic ties with Sumitomo and U.S. advisors.

Eureka Group Holdings has acquired Nagambie Lifestyle Park for $11 million, marking its ninth all-age rental community and reinforcing its affordable housing strategy in regional Victoria.

Renegade Exploration has reported rock chip assays up to 1,013 g/t silver and 8.6 g/t gold at its Broken Hills Project, confirming and expanding a mineralised epithermal zone now interpreted to stretch over two kilometres in Nevada’s Walker Lane Trend.

Saunders International has landed a $16.4 million contract to refurbish a fuel storage tank at Ampol’s Lytton Refinery, reinforcing its role in Australia’s energy infrastructure upgrades.

Alvo Minerals has confirmed significant copper, zinc, silver, and gold mineralisation at its Touro Prospect within the Palma Project in Brazil, with drilling underway to test deeper targets. This discovery bolsters the potential of Palma as a major VMS district.

Mirrabooka Investments reported a 93.6% jump in half-year profit to $8.9 million, maintaining its fully franked dividend despite portfolio returns trailing the small and mid-cap benchmark.

Kalamazoo Resources has launched the Pre-Feasibility Study for its Mt Olympus gold project amid a fresh drilling campaign, while CEO Luke Mortimer announces his departure to take a senior overseas role.

Boab Metals is set to accelerate construction at its fully funded Sorby Hills Silver-Lead Project in 2026, capitalising on silver prices currently three times higher than previous assumptions. The company aims for first concentrate production by mid-2027, supported by strategic drilling and corporate milestones.

Mirrabooka Investments Limited has announced a fully franked ordinary dividend of AUD 0.045 per share for the half-year ending December 2025, offering shareholders reinvestment and bonus share plans without discounts.

ReNerve Limited has secured market approval for its NervAlign® Nerve Cuff in Malaysia, marking a key milestone in its Asia-Pacific expansion strategy. This approval follows earlier clearances in Hong Kong and Thailand, positioning the company to tap into a growing regional nerve repair market.